Law360, New York (April 27, 2009, 12:00 AM ET) -- Reckitt Benckiser Inc. has filed a lawsuit to stop Watson Pharmaceuticals Inc. from making a generic version of the blockbuster cough treatment Mucinex.
The U.K.-based health care products company filed suit Friday in the U.S. District Court for the Southern District of Florida, accusing Watson and its subsidiary, Watson Laboratories Inc. - Florida, of infringing two patents for the drug.
The suit was filed in response to Watson's abbreviated new drug application with the U.S. Food and Drug Administration to make generic versions of both Mucinex...
Watson Pharmaceuticals Sued Over Mucinex ANDAs
To view the full article, take a free trial now.
